CVS Group plc Director/PDMR Shareholding (8026Y)
2024年1月5日 - 7:25PM
ＲＮＳを含む英国規制内ニュース （英語）
TIDMCVSG
RNS Number : 8026Y
CVS Group plc
05 January 2024
5 January 2024
CVS Group Plc
("CVS" or the "Company")
Exercise of Options, PDMR Dealing
and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary
services, announces that on 4 January 2023, options over a total of
148,032 ordinary shares of 0.2 pence each (the "Ordinary Shares")
were exercised under the CVS Group 2020 SAYE Plan (2020/2024) and
6,733 Ordinary Shares under the CVS Group Long Term Incentive Plan
2020 ("LTIP 14") .
The sum of 148,032 new Ordinary Shares were issued to satisfy
the balance of Ordinary Shares arising from the SAYE Exercise at an
exercise price of GBP10.09. Admission of the 148,032 new Ordinary
Shares has been satisfied by the Company's block listing admitted
to the London Stock Exchange on 30 December 2021.
Robin Alfonso, Chief Financial Officer exercised options over
606 Ordinary Shares in the Company under the SAYE plan. The balance
of the options were exercised by certain other employees and former
employees of the Company.
Robin Alfonso additionally exercised options over 6,733 Ordinary
Shares under the LTIP 14 scheme. The issuance of shares in
connection with the LTIP 14 exercise was fully satisfied by 6,733
Ordinary Shares held by the CVS Group Employee Benefit Trust (the
"EBT"). Following the exercise, a total of 47,945 Ordinary Shares
are held by the EBT, representing approximately 0.067% of the
Company's total voting rights.
Following his option exercises, Robin Alfonso holds a beneficial
interest in 19,896 Ordinary Shares in the Company, representing
approximately 0.028% of the total voting rights of the Company,
calculated on the same basis.
Following the issue of the new Ordinary Shares, the Company has
a total issued share capital of 71,685,694 Ordinary Shares each
carrying one voting right. The Company holds no Ordinary Shares in
treasury. Therefore, following the issue of the new Ordinary
Shares, the total number of voting rights in the Company will be
71,685,694. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
The notification below, made in accordance with the requirements
of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418
8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Robin Alfonso
------------------------------- ----------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Chief Financial Officer
------------------------------- ----------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------------- ----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name CVS Group plc
------------------------------- ----------------------------------
b) LEI 213800J41XDQ2NX48O05
------------------------------- ----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the financial Ordinary shares of 0.2 pence each
instrument, type of
instrument GB00B2863827
Identification code
b) Nature of the transaction a) Exercise of options under the 2020
SAYE Plan (1 January 2024 maturity)
b) Exercise of options under the CVS
Group Long Term Incentive Plan 2020
(4 January 2024 maturity)
----------------------------- -------------------------------------------
c) Price(s) and volume(s) Price(s) Volume
a) GBP10.09 a) 606
b) GBP0.002 b) 6,733
----------------------------- -------------------------------------------
d) Aggregated information
* Aggregated volume
7,339
* Price GBP6,128.01
----------------------------- -------------------------------------------
e) Date of the transaction a) 4 January 2023
b) 4 January 2023
----------------------------- -------------------------------------------
f) Place of the transaction a) London Stock Exchange - AIM
b) London Stock Exchange - AIM
----------------------------- -------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEAEFSEFNLEFA
(END) Dow Jones Newswires
January 05, 2024 05:25 ET (10:25 GMT)
CVS (AQSE:CVSG.GB)
過去 株価チャート
から 10 2024 まで 11 2024
CVS (AQSE:CVSG.GB)
過去 株価チャート
から 11 2023 まで 11 2024
